Literature DB >> 12762450

Selecting differentially expressed genes from microarray experiments.

Margaret Sullivan Pepe1, Gary Longton, Garnet L Anderson, Michel Schummer.   

Abstract

High throughput technologies, such as gene expression arrays and protein mass spectrometry, allow one to simultaneously evaluate thousands of potential biomarkers that could distinguish different tissue types. Of particular interest here is distinguishing between cancerous and normal organ tissues. We consider statistical methods to rank genes (or proteins) in regards to differential expression between tissues. Various statistical measures are considered, and we argue that two measures related to the Receiver Operating Characteristic Curve are particularly suitable for this purpose. We also propose that sampling variability in the gene rankings be quantified, and suggest using the "selection probability function," the probability distribution of rankings for each gene. This is estimated via the bootstrap. A real dataset, derived from gene expression arrays of 23 normal and 30 ovarian cancer tissues, is analyzed. Simulation studies are also used to assess the relative performance of different statistical gene ranking measures and our quantification of sampling variability. Our approach leads naturally to a procedure for sample-size calculations, appropriate for exploratory studies that seek to identify differentially expressed genes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12762450     DOI: 10.1111/1541-0420.00016

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  53 in total

1.  Evaluating methods for ranking differentially expressed genes applied to microArray quality control data.

Authors:  Koji Kadota; Kentaro Shimizu
Journal:  BMC Bioinformatics       Date:  2011-06-06       Impact factor: 3.169

2.  Covariate adjustment in the analysis of microarray data from clinical studies.

Authors:  Debashis Ghosh; Arul M Chinnaiyan
Journal:  Funct Integr Genomics       Date:  2004-09-17       Impact factor: 3.410

3.  Adjusting confounders in ranking biomarkers: a model-based ROC approach.

Authors:  Tao Yu; Jialiang Li; Shuangge Ma
Journal:  Brief Bioinform       Date:  2012-03-06       Impact factor: 11.622

4.  Improving the quality of biomarker discovery research: the right samples and enough of them.

Authors:  Margaret S Pepe; Christopher I Li; Ziding Feng
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-04-02       Impact factor: 4.254

5.  Immunohistochemical validation of expression microarray results.

Authors:  Lawrence True; Ziding Feng
Journal:  J Mol Diagn       Date:  2005-05       Impact factor: 5.568

6.  Identification and validation of biomarkers of IgV(H) mutation status in chronic lymphocytic leukemia using microfluidics quantitative real-time polymerase chain reaction technology.

Authors:  Lynne V Abruzzo; Lynn L Barron; Keith Anderson; Rachel J Newman; William G Wierda; Susan O'brien; Alessandra Ferrajoli; Madan Luthra; Sameer Talwalkar; Rajyalakshmi Luthra; Dan Jones; Michael J Keating; Kevin R Coombes
Journal:  J Mol Diagn       Date:  2007-08-09       Impact factor: 5.568

7.  Identification of a 5-gene signature for clinical and prognostic prediction in gastric cancer patients upon microarray data.

Authors:  Zhigang Wang; Zhi Yan; Bicheng Zhang; Zhiguo Rao; Yafei Zhang; Jian Liu; Lifang Yu; Yong Zhao; Bo Yang; Tingting Wu; Jianfei Gao
Journal:  Med Oncol       Date:  2013-08-03       Impact factor: 3.064

8.  Identification of novel stem cell markers using gap analysis of gene expression data.

Authors:  Paul M Krzyzanowski; Miguel A Andrade-Navarro
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583

9.  A boosting method for maximizing the partial area under the ROC curve.

Authors:  Osamu Komori; Shinto Eguchi
Journal:  BMC Bioinformatics       Date:  2010-06-10       Impact factor: 3.169

10.  A simulation-approximation approach to sample size planning for high-dimensional classification studies.

Authors:  Perry de Valpine; Hans-Marcus Bitter; Michael P S Brown; Jonathan Heller
Journal:  Biostatistics       Date:  2009-02-21       Impact factor: 5.899

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.